185 related articles for article (PubMed ID: 8750336)
1. N-acetylaspartate and epilepsy.
Gadian DG
Magn Reson Imaging; 1995; 13(8):1193-5. PubMed ID: 8750336
[TBL] [Abstract][Full Text] [Related]
2. Reduction in temporal N-acetylaspartate and creatine (or choline) ratio in temporal lobe epilepsy: does this 1H-magnetic resonance spectroscopy finding mean poor seizure control?
Mendes-Ribeiro JA; Soares R; Simões-Ribeiro F; Guimarães ML
J Neurol Neurosurg Psychiatry; 1998 Oct; 65(4):518-22. PubMed ID: 9771777
[TBL] [Abstract][Full Text] [Related]
3. Extent of preoperative abnormalities and focus lateralization predict postoperative normalization of contralateral 1H-magnetic resonance spectroscopy metabolite levels in patients with temporal lobe epilepsy.
Lantz G; Seeck M; Lazeyras F
AJNR Am J Neuroradiol; 2006 Sep; 27(8):1766-9. PubMed ID: 16971633
[TBL] [Abstract][Full Text] [Related]
4. Seizure frequency and bilateral temporal abnormalities: a proton magnetic resonance spectroscopy of temporal lobe epilepsy.
Someya Y; Obata T; Suhara T; Ota Y; Ikehira H; Tanada S; Hirakawa K; Okubo Y; Sasaki Y
Seizure; 2000 Jun; 9(4):274-9. PubMed ID: 10880288
[TBL] [Abstract][Full Text] [Related]
5. Value of single-voxel proton MR spectroscopy in temporal lobe epilepsy.
Achten E; Boon P; Van De Kerckhove T; Caemaert J; De Reuck J; Kunnen M
AJNR Am J Neuroradiol; 1997; 18(6):1131-9. PubMed ID: 9194441
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance spectroscopy in temporal lobe epilepsy.
Connelly A; Jackson GD; Duncan JS; King MD; Gadian DG
Neurology; 1994 Aug; 44(8):1411-7. PubMed ID: 8058140
[TBL] [Abstract][Full Text] [Related]
7. Frontal lobe N-acetylaspartate correlates with psychopathology in schizophrenia: a proton magnetic resonance spectroscopy study.
Sigmundsson T; Maier M; Toone BK; Williams SC; Simmons A; Greenwood K; Ron MA
Schizophr Res; 2003 Nov; 64(1):63-71. PubMed ID: 14511802
[TBL] [Abstract][Full Text] [Related]
8. Proton MR spectroscopy in patients with seizure disorders.
Breiter SN; Arroyo S; Mathews VP; Lesser RP; Bryan RN; Barker PB
AJNR Am J Neuroradiol; 1994 Feb; 15(2):373-84. PubMed ID: 8192088
[TBL] [Abstract][Full Text] [Related]
9. Proton magnetic resonance spectroscopy in children with temporal lobe epilepsy.
Cross JH; Connelly A; Jackson GD; Johnson CL; Neville BG; Gadian DG
Ann Neurol; 1996 Jan; 39(1):107-13. PubMed ID: 8572655
[TBL] [Abstract][Full Text] [Related]
10. Heritability heightens brain metabolite differences in schizophrenia.
Fukuzako H
J Neuropsychiatry Clin Neurosci; 2000; 12(1):95-7. PubMed ID: 10678520
[TBL] [Abstract][Full Text] [Related]
11. Proton nuclear magnetic resonance spectroscopic imaging of human temporal lobe epilepsy at 4.1 T.
Hetherington H; Kuzniecky R; Pan J; Mason G; Morawetz R; Harris C; Faught E; Vaughan T; Pohost G
Ann Neurol; 1995 Sep; 38(3):396-404. PubMed ID: 7668825
[TBL] [Abstract][Full Text] [Related]
12. Spectroscopic metabolic abnormalities in mTLE with and without MRI evidence for mesial temporal sclerosis using hippocampal short-TE MRSI.
Mueller SG; Laxer KD; Suhy J; Lopez RC; Flenniken DL; Weiner MW
Epilepsia; 2003 Jul; 44(7):977-80. PubMed ID: 12823584
[TBL] [Abstract][Full Text] [Related]
13. Application of high field spectroscopic imaging in the evaluation of temporal lobe epilepsy.
Hetherington HP; Kuzniecky RI; Pan JW; Vaughan JT; Twieg DB; Pohost GM
Magn Reson Imaging; 1995; 13(8):1175-80. PubMed ID: 8750333
[TBL] [Abstract][Full Text] [Related]
14. Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report.
Fukuzako H; Takeuchi K; Hokazono Y; Fukuzako T; Yamada K; Hashiguchi T; Obo Y; Ueyama K; Takigawa M; Fujimoto T
Psychiatry Res; 1995 Nov; 61(4):193-200. PubMed ID: 8748464
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of proton magnetic resonance spectroscopic imaging for surgical outcome in patients with intractable temporal lobe epilepsy and bilateral hippocampal atrophy.
Li LM; Cendes F; Antel SB; Andermann F; Serles W; Dubeau F; Olivier A; Arnold DL
Ann Neurol; 2000 Feb; 47(2):195-200. PubMed ID: 10665490
[TBL] [Abstract][Full Text] [Related]
16. Cognitive correlates of 1H MRSI-detected hippocampal abnormalities in temporal lobe epilepsy.
Martin RC; Sawrie S; Hugg J; Gilliam F; Faught E; Kuzniecky R
Neurology; 1999 Dec; 53(9):2052-8. PubMed ID: 10599780
[TBL] [Abstract][Full Text] [Related]
17. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
[TBL] [Abstract][Full Text] [Related]
18. [4-Tesla 1H MR spectroscopy in patients with temporal lobe epilepsy].
Schüler P; Stefan H; Schuierer G; Hentschel D; Ladebeck R; Wittig R; Huk W; Neundörfer B
Nervenarzt; 1991 Dec; 62(12):740-4. PubMed ID: 1686634
[TBL] [Abstract][Full Text] [Related]
19. Interictal 99Tc(m) HMPAO SPECT and 1H MRS in children with temporal lobe epilepsy.
Cross JH; Gordon I; Connelly A; Jackson GD; Johnson CL; Neville BG; Gadian DG
Epilepsia; 1997 Mar; 38(3):338-45. PubMed ID: 9070597
[TBL] [Abstract][Full Text] [Related]
20. Symbiosis between in vivo and in vitro NMR spectroscopy: the creatine, N-acetylaspartate, glutamate, and GABA content of the epileptic human brain.
Petroff OA; Pleban LA; Spencer DD
Magn Reson Imaging; 1995; 13(8):1197-211. PubMed ID: 8750337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
